Mohamed H. Abdel‐Rahman

University of Babylon

Full Professor(heuristic)

Ocular Oncology and Treatments · Ophthalmology

h-index51
i10-index84
Publications207
Citations42,227

Grants

9 total · 5 active

NIH #5R01CA255323-04

Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)

Expiring Soon
Amount
$584K
Period
2021-08-01 → 2026-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #5R01CA255323-03

Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)

Expiring Soon
Amount
$550K
Period
2021-08-01 → 2026-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #1R01CA255323-01A1

Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)

Expiring Soon
Amount
$581K
Period
2021-08-01 → 2026-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

9 total · 5 active

NIH #5R01CA255323-04

Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)

Expiring Soon
Amount
$584K
Period
2021-08-01 → 2026-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #5R01CA255323-03

Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)

Expiring Soon
Amount
$550K
Period
2021-08-01 → 2026-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #1R01CA255323-01A1

Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)

Expiring Soon
Amount
$581K
Period
2021-08-01 → 2026-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #5R01CA255323-02

Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)

Expiring Soon
Amount
$549K
Period
2021-08-01 → 2026-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #5R01CA255323-05

Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)

Active
Amount
$603K
Period
2021-08-01 → 2027-07-31
PIs
1
Est. capacity / PI
~1 students

Awarded at OHIO STATE UNIVERSITY

NIH #5R21CA219884-02

Evaluation of an OCA2 enhancer variant as a modifier of the phenotype of BAP1-Tumor predisposition syndrome

Amount
$165K
Period
2018-06-18 → 2021-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #1R21CA219884-01A1

Evaluation of an OCA2 enhancer variant as a modifier of the phenotype of BAP1-Tumor predisposition syndrome

Amount
$203K
Period
2018-06-18 → 2020-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #5R21CA191943-02

Hereditary cancer predisposition syndromes and uveal melanoma

Amount
$167K
Period
2014-12-08 → 2017-11-30
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #1R21CA191943-01

Hereditary cancer predisposition syndromes and uveal melanoma

Amount
$201K
Period
2014-12-08 → 2016-11-30
PIs
1
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 17 of 17
Open author page on OpenAlex →